Review: could Aromasin cause Short-term memory loss?
Summary: Short-term memory loss could be caused by Aromasin, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take Zometa, and have Breast cancer.
We study 4,764 people who have side effects while taking Aromasin from FDA and social media. Among them, 145 have Short-term memory loss. Find out below who they are, when they have Short-term memory loss and more.
How are my drugs for patients like me? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. All studies are personalized to gender and age. Start now, it's anonymous, simple & free >>>
Aromasin (latest outcomes from 4,879 users) has active ingredients of exemestane. It is often used in breast cancer, breast cancer metastatic. Commonly reported side effects of Aromasin include pain, pain exacerbated, stress and anxiety, joint pain, osteonecrosis of jaw.
Short-term memory loss
Short-term memory loss (latest reports from 461,361 patients) has been reported by people with multiple sclerosis, depression, high blood pressure, pain, pain relief by acupuncture.
On Apr, 12, 2014: 4,764 people reported to have side effects when taking Aromasin. Among them, 145 people (3.04%) have Short-term Memory Loss. They amount to 0.03% of all the 461,337 people who have Short-term Memory Loss on eHealthMe.
Time on Aromasin when people have Short-term memory loss * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Short-term memory loss||0.00%||58.33%||25.00%||0.00%||8.33%||8.33%||0.00% |
Age of people who have Short-term memory loss when taking Aromasin * :
|Short-term memory loss||0.00%||0.00%||0.00%||0.00%||0.00%||11.54%||35.38%||53.08% |
Severity of Short-term memory loss when taking Aromasin ** :
|least||moderate||severe||most severe |
|Short-term memory loss||0.00%||100.00%||0.00%||0.00% |
How people recovered from Short-term memory loss ** :
|while on the drug||after off the drug||not yet |
|Short-term memory loss||0.00%||0.00%||100.00% |
Top conditions involved for these people * :
- Breast cancer (67 people, 46.21%)
- Breast cancer metastatic (34 people, 23.45%)
- Metastases to bone (22 people, 15.17%)
- Hypercalcaemia (21 people, 14.48%)
- Pain (16 people, 11.03%)
Top co-used drugs for these people * :
- Zometa (98 people, 67.59%)
- Aredia (63 people, 43.45%)
- Femara (62 people, 42.76%)
- Nexium (58 people, 40.00%)
- Faslodex (54 people, 37.24%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Aromasin, Short-term memory loss
You can also:
On eHealthMe, Aromasin (exemestane) is often used for breast cancer. Find out below the conditions Aromasin is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Aromasin used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (4 years ago):
I am experiencing some memory impairment that seems to have started when I began taking Spironolatone for acne.
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.